CCM
PRME icon

Cinctive Capital Management’s Prime Medicine PRME Stock Holding History

Cinctive Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,033
Closed -$231K – 508
2024
Q1 		$231K Buy
+33,033
New +$251K 0.01% 368

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Cinctive Capital Management's PRME Position: Q2 2024 in Review

Cinctive Capital Management sold out of Prime Medicine (PRME) in Q2 2024, closing a stake of 33,033 shares — an estimated $231K sold.

Cinctive Capital Management first reported a position in PRME in Q1 2024 and held it in 1 quarter. The position peaked at $231K in Q1 2024. 122 funds tracked by Wall St. Rank hold PRME as of Q2 2024.

  • Cinctive Capital Management reported no remaining Prime Medicine position as of Q2 2024 after selling out during the quarter.
  • Cinctive Capital Management sold 33,033 Prime Medicine shares in Q2 2024, an estimated $231K.
  • Cinctive Capital Management first reported a position in Prime Medicine in Q1 2024 and held it in 1 quarter.
  • Cinctive Capital Management's Prime Medicine position peaked at $231K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2024.

Based on Cinctive Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.